Cargando…
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) is a life-threatening disease that is known to exhibit a poor prognosis. Therefore, it is important to identify an effective drug therapy for the treatment of HCC. Dihydromyricetin (DHM) is a flavonoid compound, isolated from the classical Chinese herb Ampelopsis gross...
Autores principales: | LIU, JIE, SHU, YANG, ZHANG, QINGYU, LIU, BIN, XIA, JUAN, QIU, MINGNING, MIAO, HUILAI, LI, MINGYI, ZHU, RUNZHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156277/ https://www.ncbi.nlm.nih.gov/pubmed/25202384 http://dx.doi.org/10.3892/ol.2014.2330 |
Ejemplares similares
-
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism
por: Zhang, Qingyu, et al.
Publicado: (2014) -
A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Lin, Bin, et al.
Publicado: (2014) -
ERRATUM: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Liu, Bin, et al.
Publicado: (2015) -
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
por: Jiang, Lianggui, et al.
Publicado: (2015) -
Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells
por: Liu, Jie, et al.
Publicado: (2016)